9th Annual Biomarkers Congress

Cell Biology: AstraZeneca

Total Score People Score Events Score
30 29 23
Date Event Presentation Speakers
July 23, 2013 EpiCongress Boston Targeting the Substrate Binding Site of Methyltranferases: Structure Based Design of SMYD2 Inhibitors Scott Cowen
April 6, 2013 AACR Annual Meetings Drug Development Track: New Drugs on the Horizon 1 Co-Chairpersons: Lori S. Friedman, Genentech, Inc., South San Francisco, CA, and Simon Bailey, Pfizer, Inc., San Diego, CA Dennis Huszar
November 15, 2011 Cosa 38th Annual Scientific Meeting The role of the pathologist in drug research and development Chris Womack
May 4, 2010 Biomarker World Congress 2010 New Era with Targeted Drugs: New Development Approaches are Needed to Achieve Success Geert J.C.M. Kolvenbag
September 23, 2009 TRACK 4: Bridging Silos in Biomarker Development : Third Annual Biomarker Data Analysis New Biomarkers: Opportunities and Challenges Anastasia M. Khoury Christianson
August 5, 2009 Targets in Context - Linking Targets to Diseases Agenda Comparison of Whole-Cell, Label-Free Assays for GPCR Drug Discovery Matthew Peters
August 5, 2009 Drug Safety Strategies to De-Risk Compounds Developing Computational Biology in Toxicology: Predictions, Data and Culture Sherri Matis-Mitchell
How Can Systems Biology Help in De-risking Molecules? David Cook
June 16, 2009 4th Annual Cell Based Assays Modelling Tumour Microenvironment by High-Content Analysis of Complex Cell Models Beverley Isherwood
Cell assay strategies for nuclear hormone receptors - the evolution of assay formats to improve quality and throughput Graeme Walker
Profiling drug mode of action through high content assays; application of multiparametric data analysis and statistical tools Peter Caie
June 10, 2009 Second Annual Hepatotoxicity and Drug Safety Monitoring Hepatotoxicity in Clinical Trials Mark H. Steinberg
June 9, 2009 Cell and Tissue-Based Assays for HTS Screening Bone Marrow Toxicity Using a Tiered Approach David Brott
June 4, 2009 Structure-Based Drug Design Supplementing Structural Information with Biophysical Data: Adding Value and Understanding in Lead Generation Stefan Geschwindner
Designing Drugs against Multiple Parameters: Scoring Functions for Multi-Parameter Ligand Based De Novo Design James R. Damewood
June 3, 2009 Inaugural Drug Induced Liver Injury The pathology of drug induced liver injury John Foster
Immunotoxicology approach to DILI by ximelagatran Karin Cederbrant
February 23, 2009 Advances and Progress in Drug Design VIII QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIPS Rupert Austin
January 28, 2009 Electronic Laboratory Notebooks USER REQUIREMENTS : Creating a simple transition from paper to electronic Ian Menzies
January 27, 2009 4th Annual Aseptic Filling and Processing Case study 1: Changes to the airborne particulate classification table – interpretation and practical issues for cleanroom operation Tim Eaton
December 2, 2008 2nd Annual Lead Discovery Summit 2008:--Primary & Secondary Screening Comparison of results obtained from acoustic and manual dispensed plates: To what extent has acoustic dispensing improved the reproducibility of results? Karen Roberts,
April 28, 2008 Clinical Development of Therapeutic Antibodies Development of a New Fully Human Anti-CD20 Gadi Bornstein
Preclinical and Clinical Safety of Monoclonal Antibodies Richard Knight
March 25, 2008 R&D Risk Mitigation Negotiating the Partnership William F Mongan
December 4, 2007 7th World Drug Discovery & Development Summit 2007 BIOMARKERS AND PERSONALISED MEDICINE OF THE FUTURE Prof. Ian Wilson
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 15: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part III) (13:30-17:00) Xiaolin Zhang
Session 15: AZD1152, an Aurora B Kinase Inhibitor, Demonstrates Potent Antitumour Efficacy in Preclinical Models (16:15-16:40) Xiaolin Zhang
October 17, 2007 Exploring Next Generation Sequencing: Applications and Case Studies (Oct 17-18) Deep Sequencing: Sensitive Detection of Somatic Mutations Using Deep Sequencing and ARMS Allele Specific PCR (14:35-15:05) Neil Gibson
Deep Sequencing (12:00-15:30) Neil Gibson
October 15, 2007 Cambridge Healthtech Institute's Third Annual Mastering Process Chemistry Oct (15-17) PROCESS OPTIMIZATION VIA ANALYTICS: Anticipation of Scale-Up Issues in Process Development: Scale Up Risk Evaluation (SURE) (16:35-17:05) Frans L. Muller
PROCESS OPTIMIZATION VIA ANALYTICS (14:00-15:05) Frans L. Muller
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Third annual Genomic Biomarkers: PHARMACOGENETICS: Major Pharmacogenetics Studies Using a Combination of Genome-Wide Tagging SNPs and High Density SNP Genotyping in Candidate Genes (10:05-10:35) Neil Gibson
Third annual Genomic Biomarkers: PHARMACOGENETICS (08:30-11:30) Neil Gibson
Eight Annual Metabolic Biomarkers: METABOLIC BIOMARKER DISCOVERY (08:30-11:00) Stephen Furlong
Eight Annual Metabolic Biomarkers; METABOLIC BIOMARKER DISCOVERY: Urine and Plasma Biomarkers in Schizophrenia (09:05-09:35) Stephen Furlong
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.